Literature DB >> 19131834

Serum procalcitonin levels in patients with multiple injuries including visceral trauma.

Marcus Maier1, Sebastian Wutzler, Mark Lehnert, Maika Szermutzky, Hendrik Wyen, Tobias Bingold, Dirk Henrich, Felix Walcher, Ingo Marzi.   

Abstract

Procalcitonin (PCT) is known to be a reliable biomarker of sepsis and infection. Elevation of serum or plasma PCT has also been observed after major surgery or trauma. The association of PCT with the severity or location of injury in multiple traumatized (polytrauma) patients has not been clearly established, to date. The aim of this study was therefore to evaluate the sensitivity of PCT as a biomarker for the diagnosis of abdominal trauma. In a prospective clinical study, PCT, interrleukin-6, and C-reactive protein were measured in blood (serum) samples obtained in the emergency room (D0) from 74 patients with multiple injuries and in serum samples obtained on the 2 days after trauma (D1, D2). PCT significantly increased during the first two posttraumatic days in patients with severe multiple injuries (n = 24, day 1: 3.37 ng/mL +/- 0.92 ng/mL; day 2: 3.27 ng/mL +/-0.97 ng/mL) as compared with patients with identical Injury Severity Score but without abdominal injury (day 1: 0.6 ng/mL +/- 0.18 ng/mL; 0.61 ng/mL +/- 0.21 ng/mL). Interrleukin-6 and C-reactive protein serum levels were not able to discriminate between patients with and without abdominal injury during the 2-day posttrauma observation period. In a specific evaluation of the abdominal injury pattern, a significant increase of serum PCT concentrations was observed on day 1 after trauma of the liver (4.04 ng/mL +/- 0.99 ng/mL) and the gut (4.63 ng/mL +/- 1.12 ng/mL) compared with other abdominal lesions (0.62 ng/mL +/- 0.2 ng/mL). Markedly elevated PCT concentrations were also evident after severe multiple injuries, including the liver/spleen in combination with thorax trauma (9.37 ng/mL +/- 2.71 ng/mL). Assessment of serum PCT seems to be significantly increased after abdominal trauma in severe multiple traumatized patients and may serve as a useful biomarker to support other diagnostic methods including ultrasound and CT scan. Although elevated levels of PCT during the first 2 days after trauma are more likely to be indicative of traumatic impact than of an ongoing status of sepsis, multiple events such as surgery, massive transfusion, and intensive care therapy might influence the PCT concentration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131834     DOI: 10.1097/TA.0b013e31817c966f

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  19 in total

Review 1.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

2.  Diagnostic value of soluble CD14 subtype (sCD14-ST) presepsin for the postmortem diagnosis of sepsis-related fatalities.

Authors:  Cristian Palmiere; Michele Mussap; Daniel Bardy; Francesco Cibecchini; Patrice Mangin
Journal:  Int J Legal Med       Date:  2012-12-22       Impact factor: 2.686

3.  Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Schönlein purpura in pediatric patients.

Authors:  Xu Teng; Yang Wang; Nan Lin; Mei Sun; Jie Wu
Journal:  Clin Rheumatol       Date:  2014-10-03       Impact factor: 2.980

4.  Diagnostic value of lipopolysaccharide-binding protein and procalcitonin for sepsis diagnosis in forensic pathology.

Authors:  Marc Augsburger; Katia Iglesias; Daniel Bardy; Patrice Mangin; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2012-10-13       Impact factor: 2.686

Review 5.  The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis.

Authors:  C-J Shen; M-S Wu; K-H Lin; W-L Lin; H-C Chen; J-Y Wu; M C-H Lee; C-C Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-21       Impact factor: 3.267

6.  Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study.

Authors:  Sari Karlsson; Milja Heikkinen; Ville Pettilä; Seija Alila; Sari Väisänen; Kari Pulkki; Elina Kolho; Esko Ruokonen
Journal:  Crit Care       Date:  2010-11-15       Impact factor: 9.097

7.  Procalcitonin and C-reactive protein levels at admission as predictors of duration of acute brain dysfunction in critically ill patients.

Authors:  Stuart McGrane; Timothy D Girard; Jennifer L Thompson; Ayumi K Shintani; Alison Woodworth; E Wesley Ely; Pratik P Pandharipande
Journal:  Crit Care       Date:  2011-03-02       Impact factor: 9.097

8.  Procalcitonin as a marker of sepsis and outcome in patients with neurotrauma: an observation study.

Authors:  Shuixiang Deng; Hechen Zhu; Kunlun Wang; Tongwa Cao
Journal:  BMC Anesthesiol       Date:  2013-12-15       Impact factor: 2.217

Review 9.  Biomarkers: a definite plus in pneumonia.

Authors:  Hanssa Summah; Jie-Ming Qu
Journal:  Mediators Inflamm       Date:  2009       Impact factor: 4.711

10.  Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity.

Authors:  K Herrmann; S Schinke; E Csernok; F Moosig; J U Holle
Journal:  Open Rheumatol J       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.